Related Experiment Video
Updated: Aug 25, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
CRISPRi screening identifies CASP8AP2 as an essential viability factor in lung cancer controlling tumor cell death
Ksenia Myacheva1, Andrew Walsh2, Marisa Riester3
1Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, German Cancer Consortium (DKTK) - Partner Site Freiburg, Germany; Division of RNA Biology & Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract:
Since lung cancer remains the leading cause of cancer death globally, there is an urgent demand for novel therapeutic targets. We carried out a CRISPR interference (CRISPRi) loss-of-function screen for human lung adenocarcinoma (LUAD) targeting 2098 deregulated genes using a customized algorithm to comprehensively probe the functionality of every resolvable transcriptional start site (TSS). CASP8AP2 was identified as the only hit that significantly affected the viability of all eight screened LUAD cell lines while the viability of non-transformed lung cells was only moderately impacted. Knockdown (KD) of CASP8AP2 induced both autophagy and apoptotic cell death pathways. Systematic expression profiling linked the AP-1 transcription factor to the CASP8AP2 KD-induced cancer cell death. Furthermore, inhibition of AP-1 reverted the CASP8AP2 silencing-induced phenotype. Overall, the tailored CRISPRi screen profiled the impact of over 2000 genes on the survival of eight LUAD cell lines and identified the CASP8AP2 - AP-1 axis mediating lung cancer viability.
Insights
A CRISPR screen identified CASP8AP2 as a key gene for lung adenocarcinoma (LUAD) survival. Its knockdown triggers cell death via autophagy and apoptosis, mediated by the AP-1 transcription factor.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer, particularly lung adenocarcinoma (LUAD), is a leading global cause of cancer mortality.
- Novel therapeutic targets are urgently needed to improve LUAD patient outcomes.
Purpose of the Study:
- To identify novel genes regulating LUAD cell viability using a large-scale CRISPR interference (CRISPRi) loss-of-function screen.
- To elucidate the molecular mechanisms underlying LUAD cell death induced by targeting key regulatory genes.
Main Methods:
- Conducted a CRISPRi loss-of-function screen targeting 2098 deregulated genes in eight LUAD cell lines.
- Utilized a customized algorithm to analyze gene functionality at the transcriptional start site (TSS) level.
- Performed knockdown (KD) of candidate genes and analyzed downstream effects on cell viability, autophagy, and apoptosis.
- Conducted systematic expression profiling to identify transcription factors involved in gene KD-induced cell death.
Main Results:
- CASP8AP2 was identified as the sole gene significantly impacting the viability of all screened LUAD cell lines, with minimal effect on non-transformed lung cells.
- CASP8AP2 KD induced both autophagy and apoptotic cell death pathways in LUAD cells.
- The AP-1 transcription factor was linked to CASP8AP2 KD-induced cancer cell death, and its inhibition reversed the observed phenotype.
Conclusions:
- The CASP8AP2 - AP-1 axis is a critical mediator of lung adenocarcinoma cell viability.
- CASP8AP2 represents a potential therapeutic target for LUAD, with its modulation influencing cancer cell death pathways.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation

